Back to Search Start Over

Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors

Authors :
Larkina, Maria
Varvashenya, Ruslan
Yuldasheva, Feruza
Plotnikov, Evgenii
Bezverkhniaia, Ekaterina
Tretyakova, Maria
Zelchan, Roman
Schulga, Alexey
Konovalova, Elena
Vorobyeva, Anzhelika
Belousov, Mikhail
Orlova, Anna
Tolmachev, Vladimir
Deyev, Sergey
Larkina, Maria
Varvashenya, Ruslan
Yuldasheva, Feruza
Plotnikov, Evgenii
Bezverkhniaia, Ekaterina
Tretyakova, Maria
Zelchan, Roman
Schulga, Alexey
Konovalova, Elena
Vorobyeva, Anzhelika
Belousov, Mikhail
Orlova, Anna
Tolmachev, Vladimir
Deyev, Sergey
Publication Year :
2024

Abstract

HER2 status determination is a necessary step for the proper choice of therapy and selection of patients for the targeted treatment of cancer. Targeted radiotracers such as radiolabeled DARPins provide a noninvasive and effective way for the molecular imaging of HER2 expression. This study aimed to evaluate tumor-targeting properties of three 99mTc-labeled DARPin G3 variants containing Gly-Gly-Gly-Cys (G3C), (Gly-Gly-Gly-Ser)3-Cys ((G3S)3C), or Glu-Glu-Glu-Cys (E3C) amino acid linkers at the C-terminus and conjugated to the HYNIC chelating agent, as well as to compare them with the clinically evaluated DARPin G3 labeled with 99mTc(CO)3 using the (HE)3-tag at the N-terminus. The labeling of DARPin G3-HYNIC variants provided radiochemical yields in the range of 50–80%. Labeled variants bound specifically to human HER2-expressing cancer cell lines with affinities in the range of 0.5–3 nM. There was no substantial influence of the linker and HYNIC chelator on the binding of 99mTc-labeled DARPin G3 variants to HER2 in vitro; however, [99mTc]Tc-G3-(G3S)3C-HYNIC had the highest affinity. Comparative biodistribution of [99mTc]Tc-G3-G3C-HYNIC, [99mTc]Tc-G3-(G3S)3C-HYNIC, [99mTc]Tc-G3-E3C-HYNIC, and [99mTc]Tc-(HE)3-G3 in healthy CD1 mice showed that there was a strong influence of the linkers on uptake in normal tissues. [99mTc]Tc-G3-E3C-HYNIC had an increased retention of activity in the liver and the majority of other organs compared to the other conjugates. The tumor uptake of [99mTc]Tc-G3-(G3S)3C-HYNIC and [99mTc]Tc-(HE)3-G3 in Nu/j mice bearing SKOV-3 xenografts was similar. The specificity of tumor targeting in vivo was demonstrated for both tracers. [99mTc]Tc-G3-(G3S)3C-HYNIC provided comparable, although slightly lower tumor-to-lung, tumor-to spleen and tumor-to-liver ratios than [99mTc]Tc-(HE)3-G3. Radiolabeling of DARPin G3-HYNIC conjugates with 99mTc provided the advantage of a single-step radiolabeling procedure; however, the studied HYNIC conjugates did not impro

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1457642454
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1021.acs.molpharmaceut.3c01173